Promotional Tracking RFK Jr. Nomination to lead HHS Gain critical insights into the perspectives of healthcare professionals (HCPs) regarding Robert F. Kennedy Jr.'s nomination as Secretary of Health and Human Services (HHS). This report highlights key findings from a survey
Oncology Global Pharma Manufacturer Perception Tracker Oncology Every day, over 54,500 people are diagnosed with cancer and more than 26,000 succumb. Pharma leaders are answering the call by increasing investments in cancer drug research and developing personalized treatments,
Promotional Tracking Global Pharma Manufacturer Perception: Vaccines The vaccine industry has undergone an unprecedented transformation in the last 5 years, driven by significant technological advancements and a renewed global focus on public health and immunization. Breakthroughs in multiple areas like
Promotional Tracking 2024 Lung Cancer Developments ZOOMRX Global Oncology Panel’s Perspectives The last couple of months have brought some high-profile developments in non-small cell lung cancer (NSCLC) including critical data released at the World Conference on Lung Cancer
Brand Builder Oncology Pipeline Perceptions - Assessing HCP Excitement AbbVie, Genentech and Jazz top list of most exciting oncology pipeline assets The Future of Oncology: Which Treatments Excite Oncologists? In the ever-evolving landscape of cancer treatment, the pipeline of new therapies holds
News Hopes and Hurdles: Rare Disease Management Creutzfeldt-Jakob disease is a degenerative brain disorder. It is fatal and occurs in 1-2 persons per 1 million population every year. Pulmonary arterial hypertension is a progressive disorder characterized by high blood pressure,
Promotional Tracking Four Myths in HCP-Sales Rep Engagements Stirring the Hornet’s Nest Engaging with healthcare professionals (HCPs) through sales representative interactions is like a delicate dance. There are established norms & firm beliefs on how it is being done. Challenging those
Promotional Tracking Driving Successful HCP-Sales Rep 'Engagements : 2023' Lookback PET Report The what and how behind the successful engagements and their trends over half a decade Understanding the Ever-Evolving HCP-Sales Rep Engagements . As we step into 2024, we look to understand 1. How HCP-Sales
Oncology Oncology Manufacturers' Perception - Insights from the Healthcare Frontline Leaders of Oncologist’s Perceptions: Who are they and what sets them apart In the highly competitive oncology therapeutics landscape, there is a direct correlation between oncologists’ preferences and financial success. That makes
Promotional Tracking Thriving Against the Odds - A Case study An Emerging Biopharma’s David vs. Goliath story in the Post Launch Space Problem: Respiratory diseases are one of the leading causes of death and hospital admissions in the US. This market is
Oncology Mindshare Masters: Top Oncology Brands that Oncologists Trust Have you ever wondered which oncology brands truly dominate and capture the mindshare oncologists in the ever-evolving field of oncology? With a staggering 100+ new molecular entities approved by the FDA (Feder
News ASCO 2023 : From the Oncologists’ Perspective ASCO Annual Meeting 2023 led with the theme of Improving Patients' Lives Through Collaboration, Research, and Innovation, creating positive experiences among those who attended and generating excitement about practice-changing data. The ZoomRx survey
Oncology Continuing the Launch Buzz: A Winning Game Plan Three Keys for Sales Rep Conversations to Keep the Launch Momentum Going Introduction: Successfully launching a pharmaceutical product is incredibly challenging, time-consuming—and costly. The stakes are high, the competition is fierce, and
What HCPs Really Think: A Revealing Look at Industry Leaders & Challengers in 5 Therapeutic Areas Healthcare providers (HCPs) are crucial decision-makers in prescribing and recommending treatments to patients. As such, their perceptions and opinions of pharmaceutical manufacturers and their products are highly relevant. Recent research indicates that two-thirds
Research Meet the Top 5 Oncology Pharmaceutical Manufacturers that Excel with MSL Guidance The oncology field is rapidly evolving, with groundbreaking CAR-T cell therapies and accessible biosimilars providing new hope for patients. However, these changes also bring new challenges in understanding and effectively utilizing these treatments.
Launch Excellence Zynyz for Merkel Cell Carcinoma: A Highly Effective but Little Known Treatment Option? Merkel Cell Carcinoma (MCC) is a rare and aggressive form of skin cancer that can be challenging to treat. Until recently, treatment options were limited, but with the advent of immunotherapy, new therapies
Launch Excellence Airsupra: The Rescue Inhaler That Helps Manage Asthma Symptoms Asthma is a chronic respiratory disease that affects millions of people worldwide. It causes inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, coughing, and chest tightness.
Launch Excellence Rykindo: A New Long-Acting Injectable Formulation of Risperidone for Schizophrenia and Bipolar I Disorder The pharmaceutical industry is constantly evolving, and one of the latest additions to the market is Rykindo, a long-acting injectable formulation of risperidone. Risperidone is an atypical antipsychotic medication used for the treatment
Launch Excellence Jaypirca: A Fresh Approach to Later-Line MCL Treatment Jaypirca (pirtobrutinib) is a novel, non-covalent Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic
Launch Excellence Leqembi's First 2 Months on the Market: Neurologists Feedback Leqembi (lecanemab) is a new Alzheimer's disease treatment option from Biogen/Eisai. The drug has a unique mechanism of action that is thought to slow down the progression of the disease by neutralizing
Launch Excellence The Latest Addition to Diabetes Treatment: A Deep Dive into Brenzavvy Type 2 diabetes is a chronic disease that affects millions of people worldwide. It is characterized by high levels of sugar in the blood due to the body's cells resisting the normal effect
Launch Excellence Hope for Patients with Anemia of CKD: FDA Approves Jesduvroq GSK plc has announced the FDA approval of Jesduvroq (daprodustat) for the treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months.
Promotional Tracking Pharma Marketers' Point of View: The Evolution of the Pharma Promotional Landscape Highlight products’ superiority and differentiability Your browser does not support the audio element. Answer questions and/or solve problems Your browser does not support the audio element. Deliver newer data, such as product
Customer Engagement Physicians' View of the Industry Giants: Ranking the Top Pharma Companies The pharmaceutical industry is constantly evolving, and the perceptions of healthcare professionals (HCPs) play a critical role in shaping the public's trust and acceptance of drugs. To understand how physicians perceive the top
Launch Excellence The Launch of Amjevita: The First Humira Biosimilar The world of autoimmune treatments has seen a new addition with the launch of Amjevita, the first Humira biosimilar. Humira, the swiss knife medication, has been available in the US since 2002 and
